Icon

VOQUEZNA TRIPLE PAK (nda215152)- (500MG;500MG;EQ 20MG BASE)

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE PHATHOM
500MG;500MG;EQ 20MG BASE
No Yes
2030-Aug-11 2027-May-03
None None
None No
VOQUEZNA TRIPLE PAK, is a co-packaged product containing vonoprazan, a potassium-competitive acid blocker (PCAB), amoxicillin, a penicillin class antibacterial, and clarithromycin, a macrolide antimicrobial, indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
500MG;500MG;EQ 20MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.